11:00Cardiac Resident Macrophage-Derived Legumain Improves Cardiac Repair by Promoting Clearance and Degradation of Apoptotic Cardiomyocytes After Myocardial Infarction -
Daile Jia Siqin Chen Peiyuan Bai Chentao Luo Jin Liu Aijun Sun Junbo Ge Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, China (D.J., P.B., J.L., A.S., J.G.). Key Laboratory of Viral Heart Diseases, National Health Commission, Shanghai, China (D.J., S.C., P.B., J.L., A.S., J.G.). Key Laboratory of Viral Heart Diseases, Chinese Academy of Medical Sciences, Shanghai, China (D.J., S.C., P.B., J.L., A.S., J.G.). Institutes of Biomedical Sciences, Fudan University, Shanghai, China (S.C., A.S., J.G.). Department of Cardiovascular (...)
Circulation
Circulation, Volume 145, Issue 20, Page 1542-1556, May 17, 2022. Background:Cardiac resident macrophages are self-maintaining and originate from embryonic hematopoiesis. After myocardial infarction, cardiac resident macrophages are responsible for the efficient clearance and degradation of (...) (Circulation)
11:01Temporal Trends in the Remaining Lifetime Risk of Cardiovascular Disease Among Middle-Aged Adults Across 6 Decades: The Framingham Study -
Ramachandran S. Vasan Danielle M. Enserro Vanessa Xanthakis Alexa S. Beiser Sudha Seshadri Boston University and the National Heart, Lung, and Blood Institute’s Framingham Heart Study, Framingham, MA (R.S.V., V.X., A.S.B., S.S.). Section of Preventive Medicine and Epidemiology, Department of Medicine, Boston University School of Medicine, MA (R.S.V., V.X.). Department of Epidemiology (R.S.V.), Boston University School of Public Health, MA. Department of Biostatistics (V.X., A.S.B.), Boston University School of Public Health, MA. NRG Oncology and Clinical Trials Development Division, (...)
Circulation
Circulation, Volume 145, Issue 17, Page 1324-1338, April 26, 2022. Background:The remaining lifetime risk (RLR) is the probability of developing an outcome over the remainder of one’s lifespan at any given age. The RLR for atherosclerotic cardiovascular disease (ASCVD) in three 20-year periods (...) (Circulation)
08:00
Circulation, Volume 145, Issue 16, Page e839-e840, April 19, 2022. (Circulation)
08:00
Circulation, Volume 145, Issue 16, Page 1285-1287, April 19, 2022. (Circulation)
08:00Percutaneous Transvalvular Microaxial Flow Pump Support in Cardiology -
Enzo Lüsebrink Antonia Kellnar Kathrin Krieg Leonhard Binzenhöfer Clemens Scherer Sebastian Zimmer Benedikt Schrage Stephanie Fichtner Tobias Petzold Daniel Braun Sven Peterss Stefan Brunner Christian Hagl Dirk Westermann Jörg Hausleiter Steffen Massberg Holger Thiele Andreas Schäfer Martin Orban Cardiac Intensive Care Unit, Medizinische Klinik und Poliklinik I (E.L., A.K., K.K., L.B., C.S., S.F., T.P., D.B., S.B., J.H., S.M., M.O.), Klinikum der Universität München, and German Center for Cardiovascular Research, partner site Munich Heart Alliance. Herzchirurgische Klinik und Poliklinik (S.P., (...)
Circulation
Circulation, Volume 145, Issue 16, Page 1254-1284, April 19, 2022. The Impella device (Impella, Abiomed, Danvers, MA) is a percutaneous transvalvular microaxial flow pump that is currently used for (1) cardiogenic shock, (2) left ventricular unloading (combination of venoarterial extracorporeal (...) (Circulation)
08:00Price and Quality in the Generic Pharmaceutical Market -
Ben Teasdale David Light Kevin A. Schulman Clinical Excellence Research Center, School of Medicine (B.T., K.A.S.), Stanford University, Palo Alto, CA. Graduate School of Business (K.A.S.), Stanford University, Palo Alto, CA. Valisure, LLC, New Haven, CT (D.L.).
Circulation
Circulation, Volume 145, Issue 16, Page 1185-1187, April 19, 2022. (Circulation)
08:00
Circulation, Volume 145, Issue 16, Page e841-e841, April 19, 2022. (Circulation)
08:00
Circulation, Volume 145, Issue 16, Page e842-e842, April 19, 2022. (Circulation)
08:00
Circulation, Volume 145, Issue 16, Page e844-e844, April 19, 2022. (Circulation)
08:00
Circulation, Volume 145, Issue 16, Page 1201-1204, April 19, 2022. (Circulation)
08:00Exercise-Induced Long Noncoding RNAs As New Players in Cardiac Hypertrophy -
Catherine A. Makarewich Thomas Thum The Heart Institute, Division of Molecular Cardiovascular Biology, Cincinnati Children’s Hospital Medical Center, OH (C.A.M.). Department of Pediatrics, University of Cincinnati College of Medicine, OH (C.A.M.). Institute of Molecular and Translational Therapeutic Strategies; REBIRTH Center for Translational Regenerative Medicine, Hannover Medical School; and Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany (...)
Circulation
Circulation, Volume 145, Issue 16, Page 1234-1237, April 19, 2022. (Circulation)